These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 870679

  • 1. Differential effects of reserpine and tetrabenazine on rat striatal synaptosomal dopamine biosynthesis and synaptosomal dopamine pools.
    Kuczenski R.
    J Pharmacol Exp Ther; 1977 May; 201(2):357-67. PubMed ID: 870679
    [Abstract] [Full Text] [Related]

  • 2. Tetrabenazine, an amine-depleting drug, also blocks dopamine receptors in rat brain.
    Reches A, Burke RE, Kuhn CM, Hassan MN, Jackson VR, Fahn S.
    J Pharmacol Exp Ther; 1983 Jun; 225(3):515-21. PubMed ID: 6864517
    [Abstract] [Full Text] [Related]

  • 3. Effects of in vivo amphetamine administration on dopamine synthesis regulation in rat brain striatal synaptosomes.
    Patrick RL, Berkowitz AL, Regenstein AC.
    J Pharmacol Exp Ther; 1981 Jun; 217(3):686-91. PubMed ID: 7229999
    [Abstract] [Full Text] [Related]

  • 4. Increase of dopamine synthesis in synaptosomes from rats treated with neuroleptics or reserpine.
    Tissari AH.
    Med Biol; 1982 Feb; 60(1):38-41. PubMed ID: 6121960
    [Abstract] [Full Text] [Related]

  • 5. Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. I. Release in the absence of vesicular transmitter stores.
    Parker EM, Cubeddu LX.
    J Pharmacol Exp Ther; 1986 Apr; 237(1):179-92. PubMed ID: 3007736
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Increased striatal dopamine synthesis is associated with decreased tissue levels of tyrosine.
    Bongiovanni R, Young D, Newbould E, Jaskiw GE.
    Brain Res; 2006 Oct 18; 1115(1):26-36. PubMed ID: 16934236
    [Abstract] [Full Text] [Related]

  • 8. Regional and subcellular distribution and some factors in the regulation of reduced pterins in rat brain.
    Bullard WP, Guthrie PB, Russo PV, Mandell AJ.
    J Pharmacol Exp Ther; 1978 Jul 18; 206(1):4-20. PubMed ID: 660556
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Contribution of vesicular and cytosolic dopamine to the increased striatal dopamine efflux elicited by intrastriatal injection of dexamphetamine.
    Watanabe S, Aono Y, Fusa K, Takada K, Saigusa T, Koshikawa N, Cools AR.
    Neuroscience; 2005 Jul 18; 136(1):251-7. PubMed ID: 16181742
    [Abstract] [Full Text] [Related]

  • 11. Trace amines inhibit the electrically evoked release of [3H]acetylcholine from slices of rat striatum in the presence of pargyline: similarities between beta-phenylethylamine and amphetamine.
    Baud P, Arbilla S, Cantrill RC, Scatton B, Langer SZ.
    J Pharmacol Exp Ther; 1985 Oct 18; 235(1):220-9. PubMed ID: 3930699
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. II. Release in the presence of vesicular transmitter stores.
    Parker EM, Cubeddu LX.
    J Pharmacol Exp Ther; 1986 Apr 18; 237(1):193-203. PubMed ID: 3007738
    [Abstract] [Full Text] [Related]

  • 14. Lobeline and nicotine evoke [3H]overflow from rat striatal slices preloaded with [3H]dopamine: differential inhibition of synaptosomal and vesicular [3H]dopamine uptake.
    Teng L, Crooks PA, Sonsalla PK, Dwoskin LP.
    J Pharmacol Exp Ther; 1997 Mar 18; 280(3):1432-44. PubMed ID: 9067333
    [Abstract] [Full Text] [Related]

  • 15. The ability of grafted human sympathetic neurons to synthesize and store dopamine: a potential mechanism for the clinical effect of sympathetic neuron autografts in patients with Parkinson's disease.
    Nakao N, Shintani-Mizushima A, Kakishita K, Itakura T.
    Exp Neurol; 2004 Jul 18; 188(1):65-73. PubMed ID: 15191803
    [Abstract] [Full Text] [Related]

  • 16. Differential dose- and time-dependent effects of molindone on dopamine neurons of rat brain: mediation by irreversible inhibition of monoamine oxidase.
    Meller E, Friedman E.
    J Pharmacol Exp Ther; 1982 Mar 18; 220(3):609-15. PubMed ID: 6121048
    [Abstract] [Full Text] [Related]

  • 17. Effects of catecholamine releasing agents on synaptosomal dopamine biosynthesis: multiple pools of dopamine or multiple forms of tyrosine hydroxylase.
    Kuczenski R.
    Neuropharmacology; 1975 Jan 18; 14(1):1-10. PubMed ID: 239360
    [No Abstract] [Full Text] [Related]

  • 18. Dopamine and neurotensin storage in colocalized and noncolocalized neuronal populations.
    Bean AJ, Adrian TE, Modlin IM, Roth RH.
    J Pharmacol Exp Ther; 1989 Jun 18; 249(3):681-7. PubMed ID: 2732943
    [Abstract] [Full Text] [Related]

  • 19. Endogenous dopamine enhances the neurotoxicity of 3-nitropropionic acid in the striatum through the increase of mitochondrial respiratory inhibition and free radicals production.
    Villarán RF, Tomás-Camardiel M, de Pablos RM, Santiago M, Herrera AJ, Navarro A, Machado A, Cano J.
    Neurotoxicology; 2008 Mar 18; 29(2):244-58. PubMed ID: 18093658
    [Abstract] [Full Text] [Related]

  • 20. Characterization of the striatal dopaminergic neurotransmission in MEN2B mice with elevated cerebral tissue dopamine.
    Mijatovic J, Patrikainen O, Yavich L, Airavaara M, Ahtee L, Saarma M, Piepponen TP.
    J Neurochem; 2008 Jun 18; 105(5):1716-25. PubMed ID: 18248620
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.